Discover the latest updates in breast cancer clinical practice and research from leading experts at the 18th St. Gallen International Breast Cancer Conference 2023 featuring key topics in early breast cancer, including immunology, the role of genomics for disease monitoring and risk stratification, as well as the anticipated St. Gallen International Consensus Session.

BCC 2023

18th St.Gallen International Breast Cancer Conference 2023
15–18 March 2023 | Vienna, Austria
VJOncology avatar; VJ Oncology @VJOncology ·
December 5, 2023 1732162169523818960

Great to speak with @KalinskyKevin (@WinshipAtEmory) at #SABCS23 who discussed tailoring treatment for premenopausal women with nodal involvement, but low genomic prognostic assay

@SABCSSanAntonio @AACR #BreastCancer #BCsm @OncoAlert

Image for the Tweet beginning: Great to speak with @KalinskyKevin Twitter feed image.
Reply on Twitter 1732162169523818960 Retweet on Twitter 1732162169523818960 0 Like on Twitter 1732162169523818960 3 Twitter 1732162169523818960
VJOncology avatar; VJ Oncology @VJOncology ·
December 5, 2023 1732138540887355677

📣 We had the pleasure of speaking with @JAMouabbi (@MDAndersonNews) on all things invasive lobular carcinoma at #SABCS23

@SABCSSanAntonio @AACR #BreastCancer #BCsm @OncoAlert

Image for the Tweet beginning: 📣 We had the pleasure Twitter feed image.
Reply on Twitter 1732138540887355677 Retweet on Twitter 1732138540887355677 1 Like on Twitter 1732138540887355677 9 Twitter 1732138540887355677
VJOncology avatar; VJ Oncology @VJOncology ·
December 5, 2023 1732127053187559908

At #SABCS23 we spoke with Wolfgang Janni of @uni_ulm who discussed the use of ctDNA for MRD detection in patients with early-stage breast cancer

@SABCSSanAntonio @AACR #BreastCancer #BCsm @OncoAlert

Image for the Tweet beginning: At #SABCS23 we spoke with Twitter feed image.
Reply on Twitter 1732127053187559908 Retweet on Twitter 1732127053187559908 0 Like on Twitter 1732127053187559908 3 Twitter 1732127053187559908
VJOncology avatar; VJ Oncology @VJOncology ·
December 5, 2023 1732094621189022121

Jincong Q. Freeman of @UChicago talks on the associations between virtual care access & psychological and mental health conditions among adults with #BreastCancer in the US

#SABCS23 @SABCSSanAntonio @AACR #BreastCancer #BCsm @OncoAlert

Image for the Tweet beginning: Jincong Q. Freeman of @UChicago Twitter feed image.
Reply on Twitter 1732094621189022121 Retweet on Twitter 1732094621189022121 1 Like on Twitter 1732094621189022121 3 Twitter 1732094621189022121
Load More

BCC 2023

18th St.Gallen International Breast Cancer Conference 2023
15–18 March 2023 | Vienna, Austria
Discover the latest updates in breast cancer clinical practice and research from leading experts at the 18th St. Gallen International Breast Cancer Conference 2023 featuring key topics in early breast cancer, including immunology, the role of genomics for disease monitoring and risk stratification, as well as the anticipated St. Gallen International Consensus Session.
VJOncology avatar; VJ Oncology @VJOncology ·
December 5, 2023 1732162169523818960

Great to speak with @KalinskyKevin (@WinshipAtEmory) at #SABCS23 who discussed tailoring treatment for premenopausal women with nodal involvement, but low genomic prognostic assay

@SABCSSanAntonio @AACR #BreastCancer #BCsm @OncoAlert

Image for the Tweet beginning: Great to speak with @KalinskyKevin Twitter feed image.
Reply on Twitter 1732162169523818960 Retweet on Twitter 1732162169523818960 0 Like on Twitter 1732162169523818960 3 Twitter 1732162169523818960
VJOncology avatar; VJ Oncology @VJOncology ·
December 5, 2023 1732138540887355677

📣 We had the pleasure of speaking with @JAMouabbi (@MDAndersonNews) on all things invasive lobular carcinoma at #SABCS23

@SABCSSanAntonio @AACR #BreastCancer #BCsm @OncoAlert

Image for the Tweet beginning: 📣 We had the pleasure Twitter feed image.
Reply on Twitter 1732138540887355677 Retweet on Twitter 1732138540887355677 1 Like on Twitter 1732138540887355677 9 Twitter 1732138540887355677
VJOncology avatar; VJ Oncology @VJOncology ·
December 5, 2023 1732127053187559908

At #SABCS23 we spoke with Wolfgang Janni of @uni_ulm who discussed the use of ctDNA for MRD detection in patients with early-stage breast cancer

@SABCSSanAntonio @AACR #BreastCancer #BCsm @OncoAlert

Image for the Tweet beginning: At #SABCS23 we spoke with Twitter feed image.
Reply on Twitter 1732127053187559908 Retweet on Twitter 1732127053187559908 0 Like on Twitter 1732127053187559908 3 Twitter 1732127053187559908
VJOncology avatar; VJ Oncology @VJOncology ·
December 5, 2023 1732094621189022121

Jincong Q. Freeman of @UChicago talks on the associations between virtual care access & psychological and mental health conditions among adults with #BreastCancer in the US

#SABCS23 @SABCSSanAntonio @AACR #BreastCancer #BCsm @OncoAlert

Image for the Tweet beginning: Jincong Q. Freeman of @UChicago Twitter feed image.
Reply on Twitter 1732094621189022121 Retweet on Twitter 1732094621189022121 1 Like on Twitter 1732094621189022121 3 Twitter 1732094621189022121
Load More
Strategies to improve the response to immunotherapy in TNBC 1:34
Strategies to improve the response to immunotherapy in TNBC
Marleen Kok • 16 Mar 2023
St. Gallen BCC 2023: translating clinical developments 1:15
St. Gallen BCC 2023: translating clinical developments
Philip Poortmans • 16 Mar 2023
Multiplexed analysis and spatial histology to predict response to immunotherapy in breast cancer 3:17
Multiplexed analysis and spatial histology to predict response to immunotherapy in breast cancer
Marleen Kok • 16 Mar 2023
Unmet needs and CDK4/6 inhibitors in HR+/HER2- early breast cancer 2:06
Unmet needs and CDK4/6 inhibitors in HR+/HER2- early breast cancer
Eva Ciruelos • 16 Mar 2023
De-escalation of axillary radiotherapy in early breast cancer 0:52
De-escalation of axillary radiotherapy in early breast cancer
Icro Meattini • 16 Mar 2023
Hereditary breast cancer at St. Gallen BCC 2023 1:07
Hereditary breast cancer at St. Gallen BCC 2023
Lisa Carey • 17 Mar 2023
Optimizing treatment in patients with early-stage HER2-positive breast cancer 4:12
Optimizing treatment in patients with early-stage HER2-positive breast cancer
Hope S. Rugo • 17 Mar 2023
Controversies in the treatment of the axilla 0:28
Controversies in the treatment of the axilla
Philip Poortmans • 16 Mar 2023
Why are we conducting clinical trials in countries that are unlikely to afford novel drugs? 3:08
Why are we conducting clinical trials in countries that are unlikely to afford novel drugs?
Sara Tolaney • 17 Mar 2023
Important considerations in the management of HR+, HER2-negative early breast cancer 2:05
Important considerations in the management of HR+, HER2-negative early breast cancer
Sara Tolaney • 17 Mar 2023
De-escalation of radiation therapy after primary systemic therapy in non-metastatic breast cancer 0:54
De-escalation of radiation therapy after primary systemic therapy in non-metastatic breast cancer
Icro Meattini • 16 Mar 2023
Remaining questions regarding the use of frontline CDK4/6 inhibitors and endocrine therapy 2:07
Remaining questions regarding the use of frontline CDK4/6 inhibitors and endocrine therapy
Sara Tolaney • 17 Mar 2023
Long-term evidence for partial breast irradiation in early breast cancer 0:41
Long-term evidence for partial breast irradiation in early breast cancer
Icro Meattini • 16 Mar 2023
Personalizing approaches in early-stage TNBC 0:58
Personalizing approaches in early-stage TNBC
Marleen Kok • 16 Mar 2023
Early breast cancer: do we need chemotherapy in low genomic/high clinical risk (ER+/HER2-)? 1:49
Early breast cancer: do we need chemotherapy in low genomic/high clinical risk (ER+/HER2-)?
Lisa Carey • 17 Mar 2023
St Gallen 2023: de-escalation, personalized treatment & adjuvant IO following neoadjuvant IO 1:08
St Gallen 2023: de-escalation, personalized treatment & adjuvant IO following neoadjuvant IO
Marleen Kok • 16 Mar 2023
The content of VJOncology is intended for healthcare professionals